Cargando…
Mecasermin for primary insulin-like growth factor-1 deficiency
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
NPS MedicineWise
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9722352/ https://www.ncbi.nlm.nih.gov/pubmed/36479333 http://dx.doi.org/10.18773/austprescr.2022.077 |
Ejemplares similares
-
Somatrogon for growth hormone deficiency
Publicado: (2022) -
Profile of mecasermin for the long-term treatment of growth failure in children and adolescents with severe primary IGF-1 deficiency
por: Fintini, Danilo, et al.
Publicado: (2009) -
Obeticholic acid for primary biliary cholangitis
Publicado: (2020) -
Mecasermin in Insulin Receptor-Related Severe Insulin Resistance Syndromes: Case Report and Review of the Literature
por: Plamper, Michaela, et al.
Publicado: (2018) -
Fostemsavir for HIV-1 infection
Publicado: (2022)